Expedition Therapeutics is listed on the portfolio pages of General Atlantic (portfolio page) and Vivo Capital (portfolio page). General Atlantic and Vivo Capital list it as current. General Atlantic has owned Expedition Therapeutics since 2026, per General Atlantic's portfolio page.
Expedition Therapeutics is a Life Sciences company. Its owner on record, General Atlantic, is a growth equity firm founded in 1980, headquartered in New York City, United States, with $125.3 billion under management. General Atlantic lists at least 40 companies in the index, 6 of them in Life Sciences. Also backed by Vivo Capital.
General Atlantic is a leading global growth equity firm that provides capital and strategic support to growth-stage companies across various sectors.
Read the General Atlantic profileHealth-care focused investment firm.
Read the Vivo Capital profileExpedition Therapeutics is listed on the portfolio pages of General Atlantic (portfolio page) and Vivo Capital (portfolio page). General Atlantic and Vivo Capital list it as current. General Atlantic has owned Expedition Therapeutics since 2026, per General Atlantic's portfolio page.
Expedition Therapeutics is in Life Sciences. Classified from the owner's portfolio label.
General Atlantic is headquartered in New York City, United States.
General Atlantic lists 5 other Life Sciences companies in the index, including Avere Therapeutics, Legent, Nurix Therapeutics, Seaport Therapeutics and U.S. Urology Partners.
6 of 39 shown
See the full General Atlantic portfolio.
6 of 97 shown
See the full Vivo Capital portfolio.
Browse PE-backed companies.
